- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-19-0050046

Voctor Pharmaceuticals Private Limited
About Voctor Pharmaceuticals Private Limited
Data last updated:
Voctor Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 17 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2019PTC334578. Its GSTIN is 37AAHCV2214P1ZY (Andhra Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10,000. It is led by directors Madhavi Vattikunta and Lakshimi Narasamma Vadlamudi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 204 Bldg No.33/A Chandivilifarm Road Sangharsh Nagar Near Chandivali Studio, Mumbai, Maharashtra, India – 400072.
As per the financials filed for FY 2024, the company reported a revenue of ₹47.91 Lakh, a growth of 103% compared to the previous year. For the same year it recorded a net profit of ₹70,512 (net margin 1.5%) and EBITDA of ₹96,031 (EBITDA margin 2%).
Voctor Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0050046).
Company details
Recognitions & Rankings of Voctor Pharmaceuticals
Contact details
Voctor Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address204 Bldg No.33/A Chandivilifarm Road Sangharsh Nagar Near Chandivali Studio, Mumbai, Maharashtra, India – 400072
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Voctor Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Voctor Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Voctor Pharmaceuticals Private Limited, buy the company report.
Financials of Voctor Pharmaceuticals Private Limited
FY 2024 filings availableVoctor Pharmaceuticals Private Limited reported revenue of ₹47.91 Lakh (up 103% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 103% in the latest year. EBITDA rose 102% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹96,031 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹70,512 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Voctor Pharmaceuticals Private Limited, buy the company report.
Board of directors of Voctor Pharmaceuticals Private Limited
Voctor Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhavi Vattikunta Also directs: Vord Pharmaceuticals Private Limited | Director | 17 Dec 2019 | 6 Years 10 Months | Current |
| Lakshimi Narasamma Vadlamudi Also directs: Vord Pharmaceuticals Private Limited | Director | 17 Dec 2019 | 6 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Voctor Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Voctor Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Voctor Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAHCV2214P1ZY | Andhra Pradesh | Active | 31 Jan 2020 |
To see the full GST registrations and return filing status of Voctor Pharmaceuticals Private Limited, buy the company report.
Recent activity
Voctor Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Lakshimi Narasamma Vadlamudi was appointed as Director on 17 Dec 2019.
Frequently asked questions
Voctor Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 17 December 2019 (7+ years old) and is registered under CIN U74999MH2019PTC334578.
Voctor Pharmaceuticals has 2 current directors:
- Madhavi Vattikunta - Director
- Lakshimi Narasamma Vadlamudi - Director
The latest financial statements of Voctor Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Voctor Pharmaceuticals is 37AAHCV2214P1ZY, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Voctor Pharmaceuticals is U74999MH2019PTC334578. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Voctor Pharmaceuticals was incorporated on 17 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
Lakshimi Narasamma Vadlamudi was appointed as Director on 17 Dec 2019. Madhavi Vattikunta was appointed as Director on 17 Dec 2019.
Yes, Voctor Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0050046).
The registered office of Voctor Pharmaceuticals is at 204 Bldg No.33A Chandivilifarm Road Sangharsh Nagar Near Chandivali Studio, Mumbai, Maharashtra, India – 400072.
Voctor Pharmaceuticals operates in the business services industry, in the miscellaneous business activities segment.

